ARTICLE | Clinical News
Alprox-TD: Started Phase III studies
November 19, 2001 8:00 AM UTC
NexMed Inc. (NEXM), Robbinsville, N.J. Product: Alprox-TD Business: Reproductive, Drug delivery Therapeutic category: Vasodilation Target: Smooth muscle cells Description: Topical formulation of alpr...